Control of associated medical conditions (hypertension, diabetes mellitus), vascular endothelial growth factor (VEGF) inhibitors, panretinal photocoagulation, medical treatment for elevated IOP, conventional glaucoma filtering surgery with antifibrotics, glaucoma valve implant surgery, and cyclodestructive procedures are among the main treatment modalities. This evidence concerns the gene VEGFA and diabetes mellitus.